BIO-key International, Inc. (BKYI)

NASDAQ: BKYI · USD

$3.11

+0.37 (+13.5%)· Recorded snapshot

Market cap	5.2M
Revenue (ttm)	6.7M
Net income (ttm)	-6M
EPS (ttm)	-$6.56
Shares out	1.7M
Volume	14,550,403
Beta	0.50

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.7M
Net income (ttm): -6M
EPS (ttm): -$6.56
Market cap: 5.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAL	American Airlines Group Inc.	8.3B	—	0.1x	3.0%	+20.0%	-6.9%	보유
ADP	Automatic Data Processing, Inc.	113B	25.3x	5.1x	62.8%	+7.7%	+4.5%	보유
ALLE	Allegion plc	15.2B	22.5x	3.5x	19.4%	+8.8%	+7.2%	보유

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-107.9

P25 n/aP50 n/aP75 n/a

ROIC-32.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BKYI indicators

Market & fundamental data

Available fields

222

Groups with data

Currency

USD

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001019034
Company name	BIO-key International, Inc.
Country	United States
Country code	US
CUSIP number	09060C606
Earnings date	2026-11-13
Earnings time	bmo
Employees	42
Employees change	0
Employees growth	0%
Enterprise value	$4.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1993
Industry	Security & Protection Services
Is primary listing	Yes
Is SPAC	No
ISIN number	US09060C6066
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2026-04-30
Last stock split type	Reverse
Market cap	$5.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$3.11
Price currency	USD
Sector	Industrials
Stock price date	2026-10-28
Symbol	BKYI
U.S. state	New Jersey
Website	https://www.bio-key.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-211.32%
EV/Sales	0.71x
FCF / EV yield	-87.73%
FCF yield	-79.1%
Forward EV/Sales	0.42x
Forward P/S	0.46x
Industry forward P/E	14.68x
Industry P/E	19.55x
P/B ratio	0.69x
P/S ratio	0.79x
Price / tangible book value	1.46x
Sector forward P/E	25.9x
Sector P/E	39.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-49.12%
EBITDA margin	-44.67%
Gross margin	81.32%
Operating margin	-49.12%
Pretax margin	-89.85%
Profit margin	-90.1%
Profit per employee	$-143,712
Revenue per employee	$159,500
ROA	-22.85%
ROA (5Y)	-37.91%
ROCE	-73.61%
ROE	-107.91%
ROE (5Y)	-149.79%
ROIC	-32.43%
SBC / revenue	2.32%
Tax / revenue	0.25%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	3
Gross profit growth	0.14%
Gross profit growth (Q)	35.8%
Gross profit growth 3Y	22.82%
Gross profit growth 5Y	10.15%
Net income growth quarters	2
Net income growth years	0
Revenue growth	-3.07%
Revenue growth (Q)	13.15%
Revenue growth (QoQ)	-10.51%
Revenue growth 10Y	7.72%
Revenue growth 3Y	-2.58%
Revenue growth 5Y	6.51%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-5,964
Depreciation and amortization	$298,119
EBIT	$-3.3M
EBITDA	$-3M
EPS	$-6.56
FCF per share	$-2.47
Financing cash flow	$3.4M
Free cash flow	$-4.2M
Free cash flow minus SBC	$-4.3M
Gross profit	$5.4M
Income taxes	$16,500
Investing cash flow	$-5,964
Net borrowing	$432,073
Net cash flow	$-896,045
Net income	$-6M
Operating cash flow minus SBC	$-4.3M
Operating income	$-3.3M
Revenue	$6.7M
Stock-based compensation	$155,642

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-24.96
Book value per share	$3.99
Debt / equity	0.2
Interest coverage	-14.19
Long-term assets	$3.7M
Long-term liabilities	$135,014
Net cash (debt)	$517,448
Net cash / market cap	9.83%
Net cash growth	-68.47%
Net debt / equity	-0.12
Piotroski F-Score	3
Property, plant and equipment	$183,525
Shareholders' equity	$4.3M
Tangible book value	$3.6M
Tangible book value per share	$3.33
Total assets	$7.5M
Total cash	$1.4M
Total debt	$861,852
Total liabilities	$3.1M
WACC	9.01%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.74
Current assets	$3.8M
Current liabilities	$3M
Current ratio	1.26
Inventory turnover	3.61
Net working capital	$192,856
Quick ratio	1.03
Working capital	$793,451
Working capital turnover	10.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-137.47%
Dividend yield	0%
Shareholder yield	-137.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-99.94%
10Y return CAGR	-52.07%
10Y total return	-99.94%
150-day SMA	$4.03
15Y price change	-99.93%
15Y return CAGR	-38.44%
15Y total return	-99.93%
1D price change	13.53%
1M price change	73.18%
1M total return	73.18%
1W price change	34.78%
1W total return	34.78%
1Y price change	-69.61%
1Y return CAGR	-69.63%
1Y total return	-69.61%
20-day SMA	$2.39
200-day SMA	$4.59
20Y price change	-99.98%
20Y return CAGR	-34.83%
20Y total return	-99.98%
3M price change	-34.74%
3M total return	-34.74%
3Y price change	-92.17%
3Y return CAGR	-57.21%
3Y total return	-92.17%
50-day SMA	$2.59
50-day SMA vs 200-day SMA	50under200
52-week high	$13.80
52-week high date	2025-11-07
52-week low	$1.55
52-week low date	2026-10-12
5Y price change	-99.44%
5Y return CAGR	-64.54%
5Y total return	-99.44%
6M price change	-48.2%
6M total return	-48.2%
All-time high	$518,399.74
All-time high date	1997-07-25
All-time low	$1.55
All-time low date	2026-10-12
Average true range (ATR)	$0.60
Average volume	8.4M
Beta (1Y)	-1.47
Beta (2Y)	0.28
Beta (5Y)	0.5
Change from 52-week high	-77.5%
Change from 52-week low	100.32%
Change from all-time high	-100%
Change from all-time low	100%
Change from open	-3.57%
Day's gap	17.73%
Dollar volume	$45.2M
High price	$3.33
Low price	$3.04
Monthly RSI	29.58
Open price	$3.22
Position in 52-week range	22.81%
Premarket change	19.2%
Premarket close	$2.74
Premarket price	$3.26
Premarket volume	8.9M
Previous close	$2.74
Price vs 150-day SMA	-23.02%
Price vs 20-day SMA	29.76%
Price vs 200-day SMA	-32.51%
Price vs 50-day SMA	19.92%
Relative volume	1.72
RSI	56.85
Sharpe ratio	-0.02
Sharpe ratio (3Y)	0.1
Sharpe ratio (5Y)	-0.27
Sortino ratio	0
Sortino ratio (3Y)	0.26
Sortino ratio (5Y)	-0.46
Volume	14.6M
Weekly RSI	43.87
YTD price change	-42.5%
YTD total return	-42.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.6M
Float percentage	94.03%
Shares change (QoQ)	0.19%
Shares change (YoY)	137.47%
Shares held by insiders	2.43%
Shares held by institutions	3.56%
Shares outstanding	1.7M
Short % of float	62.85%
Short % of shares	59.1%
Short ratio	0.1 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	265

Deeper analysis on BKYI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BKYI report

Is a complete BKYI research report available?

No complete published report is available for BIO-key International, Inc. (BKYI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BIO-key International, Inc. (BKYI)

Price

Financial snapshot

Fair-value bridge

Latest news · BKYI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BKYI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BKYI

Frequently asked questions